/ Not yet recruitingNot Applicable ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions, a Prospective, Randomised, International Trial: ShockFast IVL Trial
Coronary artery disease is caused by narrowing of the artery lumen. Treatment with Percutaneous Coronary Intervention (PCI) may be needed. This is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. Sometimes a stent is placed to keep the artery open. If the lesions in the coronary artery are calcified, this may cause difficulties for successful stent placement. The calcified plaques can be fractured via intravascular lithotripsy (IVL) with devices like ShockWave IVL and ShockFast IVL. The aim of this study is to compare the this relatively new ShockFast IVl with the more widely used ShockWave IVL.
/ Not yet recruitingNot ApplicableIIT A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of a Coronary Cutting Balloon Catheter in the Treatment of Coronary Artery Disease
/ CompletedNot ApplicableIIT Prospective, multicenter, randomized controlled clinical trial evaluating the safety and efficacy of the coronary rapamycin targeted eluting stent system for primary coronary artery stenosis lesions
100 Clinical Results associated with Shunmei Medical Co. Ltd.
0 Patents (Medical) associated with Shunmei Medical Co. Ltd.
100 Deals associated with Shunmei Medical Co. Ltd.
100 Translational Medicine associated with Shunmei Medical Co. Ltd.